Clinical and genomic characteristics of hepatocellular carcinoma-cholangiocarcinoma: Insights from real-world data.Oluseyi Abidoye, Tanios Bekaii‐Saab, Mohamad Bassam Sonbol et al.|Journal of Clinical Oncology|2025Cited by 1
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in <i>TP53</i> -mutated advanced biliary tract cancer.Taro Shibuki, Masafumi Ikeda, Celine Hoyek et al.|Journal of Clinical Oncology|2025Cited by 0
444 Impact of homologous recombination deficiency on response to chemoimmunotherapy in biliary tract cancerOluseyi Abidoye, Tanios Bekaii‐Saab, Mitesh J. Borad et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0
Prognostic role of PIK3CA and co-alterations in advanced biliary tract cancer: A multicenter retrospective analysis.Oluseyi Abidoye, Tanios S. Bekaii-Saab, Heidi Kosiorek et al.|Journal of Clinical Oncology|2026Cited by 0